Evosep is a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics. By simplifying complex proteomics processes, Evosep empowers laboratories to deliver deeper biological insights and accelerate discoveries that benefit modern healthcare and life sciences.
Company Background
- Founded in 2016, Evosep develops sample preparation and separation technologies designed for fast, robust and high-throughput protein analysis in LC-MS-based proteomics.
- The company produces instruments and consumables that support reproducible proteomics workflows used in translational research and biopharma applications.
- Evosep works closely with scientists and leading research environments, and its technologies are applied across both academic and biopharma settings.
- The company aims to make proteomics more accessible by advancing cutting-edge workflows and analytical solutions that simplify complex processes in protein analysis.
Visions & Outlook
- Accelerate Evosep’s global growth and support its mission to make proteomics more accessible and impactful through cutting-edge workflows, advanced analytics, and actionable insights.
- Scale Evosep’s platform to meet growing demand for high-performance protein analysis, where consistent and comparable results are critical for biomarker discovery, disease understanding and diagnostic development.
- Provide strategic support to accelerate product development, strengthen commercial capabilities and further expand Evosep’s presence in the proteomics market.
SECTOR
Healthcare
REVENUES 2025
EUR 23 million
EMPLOYEES
c. 80
OWNERSHIP
Nordic Capital Evolution II
INVESTMENT DATE
2025
HEAD OFFICE
Odense, Denmark